3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
190
Leukemia, Lymphocytic, Chronic, B-Cell
69
Myelodysplastic Syndromes
48
Recurrence
30
Leukemia
30
Precursor Cell Lymphoblastic Leukemia-Lymphoma
24
Lymphoma, Mantle-Cell
21
Leukemia, Myelomonocytic, Chronic
20
Leukemia, Biphenotypic, Acute
15
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
14
Hematologic Neoplasms
14
Lymphoma, Non-Hodgkin
13
Lymphoma
13
Burkitt Lymphoma
13
Lymphoma, B-Cell, Marginal Zone
12
Multiple Myeloma
11
Lymphoma, Large B-Cell, Diffuse
11
Neoplasms
10
Waldenstrom Macroglobulinemia
8
Myeloproliferative Disorders
8
Lymphoma, Follicular
8
Lymphoma, B-Cell
7
Neoplasm, Residual
6
Leukemia, Myeloid
5
Blastic Plasmacytoid Dendritic Cell Neoplasm
5
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
GATA2 Deficiency
4
Leukemia, Monocytic, Acute
3
Leukemia, B-Cell
3
Interventions
Bevacizumab
69
atezolizumab
54
durvalumab
43
lenvatinib
42
Nivolumab
38
pembrolizumab
35
tremelimumab
29
Magnetic Resonance Spectroscopy
21
Specimen Handling
19
tislelizumab
18
sintilimab
17
Ipilimumab
15
Sorafenib
14
regorafenib
13
cabozantinib
13
Radiosurgery
13
Radiotherapy
12
apatinib
11
Blood Specimen Collection
11
Immunoglobulin G
10
camrelizumab
9
Immune Checkpoint Inhibitors
9
Disulfides
9
X-Rays
8
Cyclophosphamide
8
donafenib
7
Oxaliplatin
7
Immunotherapy
7
Folfox protocol
7
Fluorouracil
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Hepatocellular
×
venetoclax
×
1 year
×
Clear all
No trials found.